INTELLIA THERAPEUTICS, INC. (NTLA) Total liabilities 2016–2025
INTELLIA THERAPEUTICS, INC. (NTLA) total liabilities at each fiscal year-end, per SEC filings.
$170.7MFY2025 · since FY2016: $89.1M → $170.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $170.7M | -46.5% |
| FY2024 | $319.1M | +27.2% |
| FY2023 | $250.8M | -11.9% |
| FY2022 | $284.5M | +11.9% |
| FY2021 | $254.2M | +70.3% |
| FY2020 | $149.3M | +131.8% |
| FY2019 | $64.4M | -7.2% |
| FY2018 | $69.4M | -8.3% |
| FY2017 | $75.6M | -15.1% |
| FY2016 | $89.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice